Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

ADMA Biologics Sees FY24 And FY25 Total Revenue Above $330M And $380M, Respectively, Up From Prior Guidance Of $320M And $370M, Respectively

Author: Benzinga Newsdesk | February 28, 2024 05:56pm

Posted In: ADMA